World Viral Vector Manufacturing Market – North America Holds 64.8% Shares Driven by Cancer and Infectious Disease
Growth of viral vector manufacturing market is expected to be driven by rising prevalence of target diseases & disorders, availability of funding for gene therapy development, effectiveness of viral vectors in gene therapy delivery, & ongoing research into viral vector-based gene & cell therapies.
Pune, India – August 10, 2018 /MarketersMedia/ —
The global viral vector manufacturing market is projected to reach USD 815.8 million by 2023 from USD 327.8 million in 2018, at a CAGR of 20%. In this report, the global market is segmented by type, disease, application, end user.
Download Free Sample Papers of Viral Vector Manufacturing Market spread across 107 Pages, Profiling 14 Companies and Supported with 50 Tables and 22 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1593765 .
The major players in global viral vector manufacturing market include Lonza (Switzerland), Merck (Germany), Oxford BioMedica (UK), CGT Catapult (UK), Cobra Biologics (UK), uniQure (Netherlands), FUJIFILM Diosynth Biotechnologies (US), and Spark Therapeutics (US).
Viral Vector Manufacturing Market, By Type
2 Retroviral Vectors
3 Lentiviral Vectors
4 Gamma-Retroviral Vectors
5 Adenoviral Vectors
6 Adeno-Associated Viral Vectors
Viral Vector Manufacturing Market, By Disease
3 Genetic Disorders
4 Infectious Diseases
Get the Corporate Discount on Viral Vector Manufacturing Market Now at https://www.reportsnreports.com/contacts/discount.aspx?name=1593765 .
Viral vector manufacturing market is segmented into cancer, genetic disorders, infectious diseases, and other diseases. During the forecast period, the genetic disorders segment is expected to grow at the highest CAGR owing to the accelerated research activities on various genetic disorders such as hemophilia A and B, sickle cell anemia, and Huntington’s disease.
1 Primary Data
2 Key Data From Primary Sources
3 Key Industry Insights
4 Secondary Data
5 Key Data From Secondary Sources
6 Market Size Estimation
7 Market Breakdown and Data Triangulation
8 Assumptions for the Study
Click now for more Details, Queries, Other Information on this study “Viral Vector Manufacturing Market by Type (Retrovirus, Gammaretrovirus, AAV), Disease (Cancer, Infectious Disease, Genetic Disorders), Application (Gene Therapy, Vaccinology), End User (Biotech companies, Research Institutes) – Global Forecast to 2023” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1593765 .
The report analyzes the viral vector manufacturing market and aims at estimating the market size and future growth potential of this market based on various aspects such as type, disease, application, end user, and region. The report also includes the competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Get the Free Analysis of Knowledge Store Now at https://www.reportsnreports.com/knowledge-store-subscription?utm_source=B-46 .
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–30% and Tier 3–30%
• By Designation – C-level–20%, Director Level–40%, Others–40%
• By Region – North America–50%, Europe–20%, Asia Pacific–20%, RoW–10%
Name: Mr. Hrishikesh
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
For more information, please visit https://www.reportsnreports.com/reports/1593765-viral-vector-manufacturing-market-by-type-retrovirus-gammaretrovirus-aav-disease-cancer-infectious-disease-genetic-disorders-application-gene-therapy-vaccinology-end-user-biotech-companies-research-i-st-to-2023.html
Release ID: 392042